2025-09-30T11:39:58-04:00 2024-12-31 WITHUMSMITHBROWN PC 1835 MARKET STREET SUITE 1710 PHILADELPHIA PA 191032945 990 2024-01-01 233100004 American Association for Cancer Research Foundation % MICHAEL STEWART AMER 2154409300 615 Chestnut Street 17th FL Philadelphia PA 191063483 MICHAEL STEWART VICE PRESIDENT, CFO 2154409300 2025-08-15 true true THOMAS PARISI P00013287 2155462140 2024 2025-03-06 01:10:19Z MICHAEL STEWART 615 Chestnut Street 17th FL Philadelphia PA 191063483 53438909 false X WWW.AACRFOUNDATION.ORG X 2000 PA ACCELERATES THE CONQUEST OF CANCER BY FUNDING SCIENTIFIC RESEARCH, EDUCATION AND COMMUNICATION. 22 21 0 500 0 0 17871430 51436405 1077000 1204000 48709 310976 7164 -12102 19004303 52939279 0 0 0 0 3523021 4081660 0 0 5265723 17355058 50255461 20878079 54337121 -1873776 -1397842 6226723 4823136 15110 15110 6211613 4808026 X THE AMERICAN ASSOCIATION FOR CANCER RESEARCH FOUNDATION ACCELERATES PROGRESS IN THE CONQUEST OF CANCER BY PROVIDING FINANCIAL SUPPORT FOR SCIENTIFIC RESEARCH, EDUCATION AND COMMUNICATION. THE FOUNDATION FUNDS PROGRAMS DEEMED BY THE AMERICAN ASSOCIATION FOR CANCER RESEARCH TO BE OF THE HIGHEST PRIORITY AND IMPACT. false false 48090050 1204000 SUPPORT TO ITS PARENT ORGANIZATION (AMERICAN ASSOCIATION FOR CANCER RESEARCH, INC.) FOR CARRYING ON ITS TAX-EXEMPTED ACTIVITIES. THIS INCLUDES RESEARCH GRANTS, SCIENTIFIC AWARDS, FELLOWSHIPS, CAREER DEVELOPMENT AWARDS, YOUNG INVESTIGATOR AWARDS, TRAVEL AWARDS AND CONFERENCE SUPPORT. 48090050 true true false false false false false false false true false false false true true true true true false false true false false false true false false false false true false false false false false false false false false false false false false true false false false true X 0 0 0 false false false false false true false false false false false true false X 22 21 true false false false false false false true true false false true true true true true true false false false AL AK AR CA CO CT DC FL GA HI IL KS KY LA ME MD MA MI MN MS MO NV NH NJ NM NY ND OH OK OR PA RI SC TN UT VA WA WV WI X X MICHAEL STEWART 2154409300 615 CHESTNUT STREET 17TH FLOOR PHILADELPHIA PA 19106 X Dr Margaret Foti Secretary and CEO 5.0 35.0 X X 201028 1809255 64914 Michael Stewart Vice President, CFO 5.0 35.0 X 22500 430500 64403 Mitchell R Stoller VP of Development, Chief Phila 40.0 0.0 X 412000 0 60020 Samuel Rogers Dir. Leadership Philanthropy 40.0 0.0 X 191363 0 34190 Danielle Triplett Director, Community Relations 40.0 0.0 X 155000 0 24843 Heather Franz Associate Dir. Leadership Phil 40.0 0.0 X 126250 0 42957 Sasha Dutton Director, Corporate Alliance 40.0 0.0 X 143640 0 23444 Lynnsay Marsan Associate Dir., Corp. Alliance 40.0 0.0 X 123586 0 30604 Stephen Ryan Chairman and President 2.0 0.0 X X 0 0 0 Dr Philip Greenberg PRESIDENT (JAN - MAR) 2.0 5.0 X X 0 0 0 Dr Patricia Larusso PRESIDENT (APR - DEC) 2.0 5.0 X X 0 0 0 Dr William Hait Treasurer 2.0 5.0 X X 0 0 0 Dr Bayard Clarkson President Emeritus 2.0 0.0 X X 0 0 0 Dr Christiana Bardon TRUSTEE 1.0 0.0 X 0 0 0 Thomas Bown II TRUSTEE 1.0 0.0 X 0 0 0 Dr James Buzzitta TRUSTEE 1.0 0.0 X 0 0 0 Lauretta Chrys TRUSTEE 1.0 0.0 X 0 0 0 Dr Nancy Davidson TRUSTEE 1.0 0.0 X 0 0 0 Dr Raymond DuBois Trustee 1.0 0.0 X 0 0 0 Cathy Fraser TRUSTEE 1.0 0.0 X 0 0 0 Tonya Hallett TRUSTEE 1.0 0.0 X 0 0 0 Dr Richard Heyman TRUSTEE 1.0 0.0 X 0 0 0 Michael Jeanis TRUSTEE 1.0 0.0 X 0 0 0 Eleanor Kress TRUSTEE 1.0 0.0 X 0 0 0 Dr John Leonard TRUSTEE 1.0 0.0 X 0 0 0 Dr Gladys Monroy TRUSTEE 1.0 0.0 X 0 0 0 Dr Anil Rustgi TRUSTEE 1.0 0.0 X 0 0 0 Dr Ajit Singh TRUSTEE 1.0 0.0 X 0 0 0 Dr Nancy Staisey TRUSTEE 1.0 0.0 X 0 0 0 Gary Steele TRUSTEE 1.0 0.0 X 0 0 0 1375367 2239755 345375 7 false true false 0 150177 51286228 51436405 DEVELOPMENT FEE FROM AACR 900099 1204000 1204000 1204000 47149 0 47149 0 0 0 0 0 722897 459070 263827 263827 263827 28458 150177 40560 -12102 -12102 0 0 0 0 0 0 0 52939279 1204000 0 298874 0 0 0 0 702490 122594 579896 0 2609528 455397 2154131 200802 35042 165760 357849 62449 295400 210991 36821 174170 0 0 27000 6845 20155 0 0 5145 5145 990461 990461 91817 91817 0 310581 193570 117011 0 155439 60121 95318 92402 92402 48090050 48090050 232636 232636 0 0 0 15365 15365 MISCELLANEOUS 119290 119290 AUDIO VISUAL 90917 90917 DUPLICATION, PRINTING 34358 3364 30994 54337121 48090050 981348 5265723 X 0 0 0 0 65000 80000 0 0 0 0 0 0 0 0 0 0 7135 26969 0 0 0 0 0 0 0 0 0 0 6154588 4716167 6226723 4823136 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 15110 15110 15110 15110 X 3210979 1541380 3000634 3266646 6211613 4808026 6226723 4823136 -1397842 -5745 X false true X true false X X X 1 AACR INC 236251648 10 true 48090050 0 1 48090050 0 49902395 41271819 28756523 17871430 51436405 189238572 0 0 49902395 41271819 28756523 17871430 51436405 189238572 45023477 144215095 37538 40461 27286 42524 47149 194958 0 0 189433530 8231454 0.76130 0.93730 X true false false false false false false false false false false false false false false true false RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 2935634 308086 57074 3186646 2666035 461096 191497 2935634 3334623 -606089 62499 2666035 3316273 218340 199990 3334623 2768887 597386 50000 3316273 0.00000 1.00000 0.00000 false true true RECEIVABLE FROM AFFILIATE 4716167 4716167 0 GIFT ANNUITY OBLIGATION 15110 15110 X 52968949 -5745 -5745 52974694 5145 -40560 -35415 52939279 54372536 40560 40560 54331976 5145 5145 54337121 PART V, LINE 4 INTENDED USES OF THE ENDOWMENT FUNDS THE INCOME FROM THE FUNDS IS AVAILABLE FOR EDUCATIONAL SESSIONS AT THE AACR ANNUAL MEETING AND OTHER PURPOSES. PART X, LINE 2 The AACR Foundation is exempt from federal income taxes under Section 501(c) (3) of the Internal Revenue Code; therefore, no provision or liability for income taxes is included in the accompanying financial statements. GAAP prescribes a minimum recognition threshold that a tax position is required to meet in order to be recognized in the financial statements. The AACR Foundation believes that it had no uncertain tax positions. PART XI, LINE 4B - OTHER ADJUSTMENTS Fundraising event expenses - $(40,560) PART XII, LINE 2D - OTHER ADJUSTMENTS FUNDRAISING EVENT EXPENSES - $ 40,560 East Asia and the Pacific Fundraising N/A 0 0 0 false false false false false false FORM 990, SCHEDULE F, PART I, LINE 3: THE ENTITY PREPARES SCHEDULE F DUE TO REVENUES GREATER THAN $10,000 RECEIVED FROM SOURCES OUTSIDE THE USA. AM 5K RUN 178635 150177 28458 40560 0 178635 150177 28458 40560 40560 -12102 X true true false false false false false false false false false Dr Margaret Foti Secretary and CEO 130000 1170000 45000 405000 26028 234255 2760 24840 3731 33583 207519 1867678 0 0 Michael Stewart Vice President, CFO 22500 427500 0 3000 0 0 1800 34200 1439 26964 25739 491664 0 0 Mitchell R Stoller VP of Development, Chief Phila 412000 0 0 0 0 0 32960 0 27060 0 472020 0 0 0 Samuel Rogers Dir. Leadership Philanthropy 191363 0 0 0 0 0 15309 0 18881 0 225553 0 0 0 Danielle Triplett Director, Community Relations 155000 0 0 0 0 0 12400 0 12443 0 179843 0 0 0 Heather Franz Associate Dir. Leadership Phil 126250 0 0 0 0 0 10100 0 32857 0 169207 0 0 0 Sasha Dutton Director, Corporate Alliance 143640 0 0 0 0 0 11491 0 11953 0 167084 0 0 0 Lynnsay Marsan Associate Dir., Corp. Alliance 123586 0 0 0 0 0 9887 0 20717 0 154190 0 0 0 PART I, LINE 1A: IT IS THE POLICY OF THE FOUNDATION TO AUTHORIZE FIRST CLASS TRAVEL ARRANGEMENTS FOR THE CHIEF EXECUTIVE OFFICER IN ORDER TO ACCOMMODATE BUSINESS TRAVEL SCHEDULES AND FACILITATE ONGOING BUSINESS TRANSACTIONS. PART I, LINE 3: COMPENSATION OF THE FOUNDATION CEO IS DETERMINED BY THE PARENT ORGANIZATION, AMERICAN ASSOCICATION FOR CANCER RESEARCH, INC. (501(C)(3) CORPORATION) AND THE FOLLOWING METHODS ARE UTILIZED: COMPESATION COMMITTEE, COMPENSATION SURVEY OR STUDY, FORM 990 OF OTHER ORGANIZATIONS, AND APPROVAL BY THE BOARD OR COMPENSATION COMMITTEE. PART II, BONUS AND INCENTIVE COMPENSATION: IN 2024, THE AACR CEO RECEIVED A ONE-TIME PAYMENT OF $450,000 ASSOCIATED WITH THE DEFERRAL OF MERIT INCREASES FOR THE PAST FIVE YEARS - 2019-2023. PART II, OTHER REPORTABLE COMPENSATION: THE EMPLOYMENT CONTRACT FOR THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, INC. CEO CALLS FOR ANNUAL CONTRIBUTIONS TO A DEFERRED COMPENSATION PLAN. DUE TO STATUTORY AND REGULATORY REQUIREMENTS, A PORTION OF THESE ANNUAL PAYMENTS CAN NO LONGER BE DEFERRED INTO A QUALIFIED PLAN AND MUST BE PAID OUT ANNUALLY AND CLASSIFIED AS OTHER REPORTABLE COMPENSATION. IN ADDITION, THE COMPANY PROVIDES AN ANNUAL CAR ALLOWANCE THAT IS ALSO INCLUDED AS PART OF OTHER COMPENSATION. FORM 990, PART VI, SECTION B, LINE 11B: PRIOR TO ITS FILING WITH THE IRS, A COPY OF FINAL FORM 990 IS PROVIDED TO EACH MEMBER OF ITS GOVERNING BODY AND TO ITS AUDIT AND FINANCE COMMITTEE ON AN ANNUAL BASIS AS PART OF THEIR FIDUCIARY RESPONSIBILITY TO UNDERSTAND AND REVIEW THE ORGANIZATION'S FINANCES. FORM 990, PART VI, SECTION B, LINE 12C: EACH MEMBER OF THE GOVERNING BODY IS REQUIRED TO ANNUALLY ACKNOWLEDGE ANY CONFLICTS BY SIGNING THE CORPORATE CONFLICT OF INTEREST STATEMENT AND DETAILING ALL POTENTIAL CONFLICTS. FORM 990, PART VI, SECTION B, LINE 15: COMPENSATION IS DETERMINED BY THE PARENT ORGANIZATION, AMERICAN ASSOCIATION FOR CANCER RESERACH, INC. (501(C)(3) CORPORATION). THE FOLLOWING METHOD IS USED: INDEPENDENT DATA DETAILING COMPARABLE COMPENSATION IS PURCHASED ANNUALLY AND PROVIDED TO A COMPENSATION COMMITTEE WHICH EVALUATES SALARY LEVELS IN COMPARISON TO PEER GROUPS. FORM 990, PART VI, SECTION C, LINE 19: FINANCIAL STATEMENTS AND THE FORM 990 ARE POSTED ON THE WEBSITE. IN ADDITION, THEY WILL BE PROVIDED ON REQUEST AND AVAILABLE FOR INSPECTION AT THE FOUNDATION'S OFFICE. FORM 990, PART VII, AND IX, LINE 5 TO 10, SALARIES AND EMPLOYEE BENEFITS THE FOUNDATION DOES NOT HAVE ITS OWN EMPLOYEES. THE EXPENSES REPORTED ON THESE LINES REPRESENT THE AMOUNTS ALLOCATED FROM THE PARENT ORGANIZATION, AMERICAN ASSOCIATION FOR CANCER RESEARCH, INC. (501(C)(3) CORPORATION) FOR THOSE EMPLOYEES WHOSE TIME IS DEVOTED TO THE FOUNDATION. FORM 990, PART VII, SECTION A, COMPENSATION FROM RELATED ORGANIZATION FOR THE CEO AND CFO, THE ALLOCATION IS BASED UPON AN ESTIMATE OF THE AMOUNT OF THEIR TIME SPENT IN THIS AREA - 10% FOR THE CEO, 5% FOR THE CFO. FORM 990, PART V, LINE 1A: NO W-2S ARE ISSUED BY THE FOUNDATION. EMPLOYEES ARE REPORTED ON W-2S ISSUED BY THE PARENT ORGANIZATION, AMERICAN ASSOCIATION FOR CANCER RESEARCH, INC. (501(C)(3) CORPORATION) UNDER THEIR EIN. FORM 990, PART VI, SECTION A, LINE 2: A BUSINESS RELATIONSHIP EXISTS AS CERTAIN TRUSTEES SERVE ON THE BOARD OF THE PARENT ORGANIZATION, AMERICAN ASSOCIATION FOR CANCER RESEARCH, INC., WHICH PROVIDES COMPENSATION TO THE CEO AND CFO. AMERICAN ASSOCIATION FOR CANCER RESEARCH 615 CHESTNUT STREET PHILADELPHIA PA 19106 236251648 SEE SCH O NY 501(C)(3) LINE 10 NA false AMERICAN ASSOCIATION FOR CANCER RESEARCH C/O TMF CANADA MANAGEMENT INC 330 TORONTO ONTARIO CA SEE SCH O CA 501(C)(3) LINE 10 AACR true false true false false false false false false false false false true false true true false false false true American Association for Cancer Research B 48090050 ACCRUAL METHOD American Association for Cancer Research S 1204000 ACCRUAL METHOD PART II, IDENTIFICATION OF RELATED TAX EXEMPT ORGANIZATIONS. NAME AND ADDRESS OF RELATED ORGANIZATION: AMERICAN ASSOCIATION FOR CANCER RESEARCH INTERNATIONAL - CANADA C/O TMF CANADA MANAGEMENT INC., 330 BAY STREET, SUITE 820 TORONTO, ONTARIO, CANADA DIRECT CONTROLLING ENTITY: AMERICAN ASSOCIATION FOR CANCER RESEARCH, INC. PART II, COLUMN (B) PRIMARY ACTIVITIES THE PURPOSE OF THE AMERICAN ASSOCIATION OF CANCER RESEARCH IS TO FOSTER RESEARCH IN CANCER AND RELATED BIOMEDICAL SCIENCE; ACCELERATE THE DISSEMINATION OF NEW RESEARCH FINDINGS AMONG SCIENTISTS AND OTHERS DEDICATED TO THE CONQUEST OF CANCER; PROMOTE SCIENCE EDUCATION AND TRAINING; AND ADVANCE THE UNDERSTANDING OF CANCER ETIOLOGY, PREVENTION, DIAGNOSIS AND TREATMENT THROUGHOUT THE WORLD. THE PURPOSE OF AACR INTERNATIONAL - CANADA IS TO PROMOTE HEALTH BY SUPPORTING, MANAGING AND CONDUCTING NEW AND INNOVATIVE RESEARCH FOR THE CURE, PREVENTION AND TREATMENT OF CANCER, AND BY FOSTERING COLLABORATION AMONGST SCIENTISTS ENGAGED IN CANCER RESEARCH. IT INTENDS TO ADVANCE EDUCATION BY DEVELOPING AND OPERATING PROGRAMS, CONFERENCES, SEMINARS AND WORKSHOPS DESIGNED TO TRAIN STUDENTS AND SCIENTISTS AND ADVANCE THEIR UNDERSTANDING OF CANCER ETIOLOGY, PREVENTION, DIAGNOSIS AND TREATMENT.